The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 27, 2022
Filed:
Jul. 24, 2019
Applicant:
Affimed Gmbh, Heidelberg, DE;
Inventors:
Joachim Koch, Heidelberg, DE;
Martin Treder, Heidelberg, DE;
Jens Pahl, Dossenheim, DE;
Uwe Reusch, Maikammer, DE;
Thorsten Ross, Edingen-Neckarhausen, DE;
Erich Rajkovic, Schriessheim, DE;
Adelheid Cerwenka, Heidelberg, DE;
Assignee:
AFFIMED GMBH, Heidelberg, DE;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 38/20 (2006.01); C07K 16/28 (2006.01); C07K 14/54 (2006.01); C07K 14/55 (2006.01); A61K 38/19 (2006.01);
U.S. Cl.
CPC ...
C07K 16/283 (2013.01); A61K 38/19 (2013.01); A61K 38/204 (2013.01); A61K 38/208 (2013.01); A61K 38/2013 (2013.01); A61K 38/2086 (2013.01); A61K 39/39558 (2013.01); C07K 14/5412 (2013.01); C07K 14/5434 (2013.01); C07K 14/5443 (2013.01); C07K 14/55 (2013.01); C07K 16/2878 (2013.01); A61K 38/20 (2013.01); C07K 14/54 (2013.01); C07K 2317/34 (2013.01); C07K 2317/626 (2013.01); C07K 2317/732 (2013.01);
Abstract
The invention relates to an anti-CD16A antigen binding protein for use in NK cell-based immunotherapy, wherein the anti-CD16A antigen binding protein is to be administered intermittently and in combination with a cytokine. In certain embodiments the antigen binding protein is a tetravalent and bispecific CD30/CD16A tandem diabody.